Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12590103 | Polymorph of EP4 receptor antagonist, preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-31 | 2041-01-29 | 0 | 31 |
| 12589152 | Composition for enhanced absorption of supplements | 🖼🧊📄§ | 2026-03-31 | 2042-12-16 | 0 | 31 |
| 12589119 | Treatment of cachexia using fibroblast cells and products thereof | 🖼🧊📄§ | 2026-03-31 | 2039-11-04 | 0 | 31 |
| 12590320 | Cellular models of and therapies for ocular diseases | 🖼🧊📄§ | 2026-03-31 | 2038-07-31 | 0 | 31 |
| 12589112 | Oncolytic virus compositions including IL-15 complex and methods for the treatment of cancer | 🖼🧊📄§ | 2026-03-31 | 2041-01-22 | 0 | 31 |
| 12590136 | Engineered T cells | 🖼🧊📄§ | 2026-03-31 | 2040-05-07 | 0 | 31 |
| 12589117 | Mesenchymal stem cell-derived extracellular vesicles and uses thereof for treating and diagnosing fibrotic diseases | 🖼🧊📄§ | 2026-03-31 | 2042-07-18 | 0 | 31 |
| 12590159 | Compositions targeting epidermal growth factor receptor and methods for making and using the same | 🖼🧊📄§ | 2026-03-31 | 2045-02-25 | 0 | 31 |
| 12589127 | Bacteriophages for treatment of tuberculosis | 🖼🧊📄§ | 2026-03-31 | 2044-05-23 | 0 | 31 |
| 12589081 | Curcumin compositions for osteoarthritis and joint wellness | 🖼🧊📄§ | 2026-03-31 | 2040-12-02 | 0 | 31 |
| 12590151 | Anti-human CD19 antibodies with high affinity | 🖼🧊📄§ | 2026-03-31 | 2042-11-03 | 0 | 31 |
| 12589160 | Peptide-derived therapeutics targeting KDM5C for the treatment of cancer | 🖼🧊📄§ | 2026-03-31 | 2040-03-12 | 0 | 31 |
| 12589093 | Plasma kallikrein inhibitors and methods of use thereof in ocular disorders | 🖼🧊📄§ | 2026-03-31 | 2040-04-08 | 0 | 31 |
| 12589079 | Gene delivery system and application thereof in preparation of drugs for treatment of tumors | 🖼🧊📄§ | 2026-03-31 | 2045-05-10 | 0 | 31 |
| 12589140 | Antigen-presenting neutrophil-derived dendritic cells and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-01-22 | 0 | 31 |
| 12590100 | Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the NRF2-β-TrCP interaction for use in the treatment of fatty liver disease | 🖼🧊📄§ | 2026-03-31 | 2042-01-13 | 0 | 31 |
| 12590157 | Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments | 🖼🧊📄§ | 2026-03-31 | 2043-07-20 | 0 | 31 |
| 12589080 | Enhanced two-stage microparticle-based localized therapeutic delivery system | 🖼🧊📄§ | 2026-03-31 | 2042-06-01 | 0 | 31 |
| 12589118 | Method of prolonging the lifespan of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) using a cerebrolysin® preparation | 🖼🧊📄§ | 2026-03-31 | 2038-08-28 | 0 | 31 |
| 12590150 | Antibody against Nectin-4 and application thereof | 🖼🧊📄§ | 2026-03-31 | 2041-04-21 | 0 | 31 |
| 12590161 | Anti-C-MPL antibody and use thereof | 🖼🧊📄§ | 2026-03-31 | 2041-11-09 | 0 | 31 |
| 12590090 | Pyrimidine-and nitrogen-containing bicyclic compound | 🖼🧊📄§ | 2026-03-31 | 2040-09-30 | 0 | 31 |
| 12589157 | Compositions of drug delivery agents and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2039-03-29 | 0 | 31 |
| 12589069 | Ophthalmic suspension composition | 🖼🧊📄§ | 2026-03-31 | 2042-12-21 | 0 | 31 |
| 12590063 | Phenol derivative | 🖼🧊📄§ | 2026-03-31 | 2041-09-03 | 0 | 31 |
| 12589166 | Compositions and methods for treating wounds | 🖼🧊📄§ | 2026-03-31 | 2041-05-13 | 0 | 31 |
| 12588679 | Systems, methods, and apparatuses for disinfection and decontamination | 🖼🧊📄§ | 2026-03-31 | 2043-03-21 | 0 | 31 |
| 12589165 | Methods for treating bladder tumors with viral nanoparticle conjugates and immune checkpoint inhibitors | 🖼🧊📄§ | 2026-03-31 | 2038-04-11 | 0 | 31 |
| 12589136 | Viral vectors comprising RDH12 coding regions and methods of treating retinal dystrophies | 🖼🧊📄§ | 2026-03-31 | 2042-08-09 | 0 | 31 |
| 12590168 | Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof | 🖼🧊📄§ | 2026-03-31 | 2044-01-23 | 0 | 31 |
| 12589149 | Method of modulating mucosal immunogenicity | 🖼🧊📄§ | 2026-03-31 | 2040-03-18 | 0 | 31 |
| 12590093 | Indolo[2′,3′:3,4]pyrido[2,1-b]quinazoline compound and use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-09-27 | 0 | 31 |
| 12589109 | Therapy to stimulate hippocampal neural progenitors and adult neurogenesis | 🖼🧊📄§ | 2026-03-31 | 2041-09-03 | 0 | 31 |
| 12589064 | Trolox-peptide conjugate and use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-05-06 | 0 | 31 |
| 12589164 | Protease-cleavable substrates and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2045-03-14 | 0 | 31 |
| 12589124 | Bifidobacterium longum | 🖼🧊📄§ | 2026-03-31 | 2041-03-12 | 0 | 31 |
| 12590295 | Mesenchymal stromal cells as a reprogramming source for iPSC induction | 🖼🧊📄§ | 2026-03-31 | 2040-11-27 | 0 | 31 |
| 12589144 | Combined norovirus and rotavirus vaccine composition and methods of preparation | 🖼🧊📄§ | 2026-03-31 | 2041-01-06 | 0 | 31 |
| 12589158 | GLP-1/GIP dual agonist, preparation method and use thereof | 🖼🧊📄§ | 2026-03-31 | 2044-03-12 | 0 | 31 |
| 12590312 | NR4A super-repressors and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-05-21 | 0 | 31 |
| 12589104 | Thiosaccharides for use in treating coronavirus infection | 🖼🧊📄§ | 2026-03-31 | 2041-05-11 | 0 | 31 |
| 12589099 | Alpha-1062 for treating traumatic brain injury | 🖼🧊📄§ | 2026-03-31 | 2042-11-25 | 0 | 31 |
| 12590139 | MHC class II molecules and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-07-29 | 0 | 31 |
| 12589113 | Preparation of a therapeutic composition for treating autoimmune diseases | 🖼🧊📄§ | 2026-03-31 | 2044-10-01 | 0 | 31 |
| 12590124 | Peptide with neutralizing activity against severe acute respiratory syndrome coronavirus 2 | 🖼🧊📄§ | 2026-03-31 | 2041-07-15 | 0 | 31 |
| 12590098 | Pyrimido pyrimidinone compound and pharmaceutical composition comprising the same | 🖼🧊📄§ | 2026-03-31 | 2041-09-15 | 0 | 31 |
| 12590123 | Compounds and methods for treating cancer, viral infections, and allergic conditions | 🖼🧊📄§ | 2026-03-31 | 2040-06-25 | 0 | 31 |
| 12590141 | Monoclonal antibodies against Henipavirus glycoprotein G and encoding nucleic acids thereof | 🖼🧊📄§ | 2026-03-31 | 2041-06-27 | 0 | 31 |
| 12590125 | Peptide inhibitors for the inhibition of HIV capsid | 🖼🧊📄§ | 2026-03-31 | 2040-06-08 | 0 | 31 |
| 12590149 | Antibody and bispecific antibody targeting LAG-3 and use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-06-11 | 0 | 31 |